Lombardi Comprehensive Cancer Center at Georgetown University is a clinical research site located in Georgetown, Washington, United States 20057.
Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Lombardi Comprehensive Cancer Center at Georgetown University has participated in 1 clinical trials.
Therapeutic areas: Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.
Sponsors: Spur Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Georgetown
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lombardi Comprehensive Cancer Center at Georgetown University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Comprehensive Cancer Center at Georgetown University has 1 clinical trials on record. Their work covers Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.
Lombardi Comprehensive Cancer Center at Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.